Thiam gets his scalpel out, but he should invest in IBD
Credit Suisse’s new CEO has signalled a commitment to the bank's corporate finance business. But he will need to invest in it, writes David Rothnie.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts